Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 914348-82-6 | MDL No. : | MFCD05864660 |
Formula : | C11H9NO2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DFJPGTVCVKDDEY-UHFFFAOYSA-N |
M.W : | 219.26 | Pubchem ID : | 45036824 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.09 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 59.43 |
TPSA : | 67.43 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.95 cm/s |
Log Po/w (iLOGP) : | 2.08 |
Log Po/w (XLOGP3) : | 2.38 |
Log Po/w (WLOGP) : | 2.63 |
Log Po/w (MLOGP) : | 0.82 |
Log Po/w (SILICOS-IT) : | 3.8 |
Consensus Log Po/w : | 2.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.04 |
Solubility : | 0.198 mg/ml ; 0.000905 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.44 |
Solubility : | 0.0802 mg/ml ; 0.000366 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.9 |
Solubility : | 0.0279 mg/ml ; 0.000127 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; Stage #2: at 0℃; Stage #3: With acetic acid In tetrahydrofuran; hexane |
(b)-1; Palladium acetate (0.82 g, 3.66 mmol), triphenylphosphine (4.80 g, 18.29 mmol), and a 2 M-sodium carbonate aqueous solution (183.0 mL, 366.0 mmol) were added to a solution of 2-bromothiazole (20.00 g, 121.94 mmol) and 4-methoxyphenylboric acid (25.94 g, 170.71 mmol) in DMF (400 mL). The obtained mixture was stirred at 100°C for 3 hours. Thereafter, water was added to the reaction solution, and it was then extracted with a mixture of ethyl acetate and toluene (1 : 1). The extract was washed with water and a saturated saline, and it was then dried over anhydrous sodium sulfate, followed by concentration. The residue was purified by silica gel column chromatography (hexane/ethyl acetate) to obtain a thiazole compound (20.40 g, yield: 88percent) in the form of a yellow oily substance. Thereafter, n-butyl lithium (2.64 M hexane solution, 52.5 mL, 138.67 mmol) was added dropwise to a solution of the obtained thiazole compound (20.40 g, 106.67 mmol) in THF (500 mL) at -78°C. After stirring for 2 hours, DMF (16.4 mL, 213.33 mmol) was added dropwise to the reaction solution, and the reaction temperature was then raised to 0°C. The solution was stirred for 2 hours. Thereafter, acetic acid (7.9 mL, 138.67 mmol) was added dropwise to the reaction solution, and the solvent was then distilled away. The residue was dissolved in ethyl acetate, and water was then added to the solution and the two layers were separated. The water layer was extracted with ethyl acetate. The combined organic layer was washed with water and a saturated saline, and it was then dried over anhydrous sodium sulfate, followed by concentration. The residue was recrystallized from diisopropyl ether to obtain an aldehyde compound (18.31 g, yield: 78percent) in the form of a yellow powder. |
[ 1011-40-1 ]
2-Phenylthiazole-5-carbaldehyde
Similarity: 0.85
[ 10058-38-5 ]
2-Phenylthiazole-5-carboxylic acid
Similarity: 0.82
[ 172678-67-0 ]
Ethyl 2-phenylthiazole-5-carboxylate
Similarity: 0.82
[ 161797-99-5 ]
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.79
[ 161798-03-4 ]
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.76
[ 1011-40-1 ]
2-Phenylthiazole-5-carbaldehyde
Similarity: 0.85
[ 161798-03-4 ]
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.76
[ 161798-01-2 ]
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.75
[ 161798-03-4 ]
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.76
[ 10205-71-7 ]
4-(6-Methoxybenzo[d]thiazol-2-yl)-N,N-dimethylaniline
Similarity: 0.75
[ 160844-75-7 ]
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
Similarity: 0.74
[ 57677-80-2 ]
2-(4-Methoxyphenyl)thiazole-4-carboxylic acid
Similarity: 0.73
[ 101078-51-7 ]
6-Methoxy-2-(p-tolyl)benzo[d]thiazole
Similarity: 0.72
[ 1011-40-1 ]
2-Phenylthiazole-5-carbaldehyde
Similarity: 0.85
[ 10058-38-5 ]
2-Phenylthiazole-5-carboxylic acid
Similarity: 0.82
[ 172678-67-0 ]
Ethyl 2-phenylthiazole-5-carboxylate
Similarity: 0.82
[ 161797-99-5 ]
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.79
[ 161798-03-4 ]
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
Similarity: 0.76